Volume 13, Number 1—January 2007
Multidrug-resistant Acinetobacter Infection Mortality Rate and Length of Hospitalization
|Outcome evaluated||MDR Acinetobacter vs. susceptible† OR (95% CI)||MDR Acinetobacter vs. uninfected† OR (95% CI)|
|Length of stay, d||2.5 (1.2–5.2)||2.5 (1.2–5.4)|
|Intensive care unit length of stay, d||2.1 (1.0–4.3)||4.2 (1.5–11.6)|
|Mortality rate (%)||2.6 (0.3–26.1)||6.6 (0.4–108.3)|
*OR, odds ratio; CI, confidence interval.
†Models include modified Acute Physiology and Chronic Health Evaluation III score to control for severity of illness and Charlson index to control for underlying disease.
- Page created: June 28, 2010
- Page last updated: June 28, 2010
- Page last reviewed: June 28, 2010
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)